Essex Woodlands Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11M | Hold |
1,169,857
| – | – | 3.94% | 3 |
|
2025
Q1 | $6.34M | Hold |
1,169,857
| – | – | 1.83% | 3 |
|
2024
Q4 | $8.72M | Sell |
1,169,857
-381,664
| -25% | -$2.84M | 2.01% | 4 |
|
2024
Q3 | $12.4M | Hold |
1,551,521
| – | – | 3.54% | 3 |
|
2024
Q2 | $13.5M | Hold |
1,551,521
| – | – | 4.4% | 4 |
|
2024
Q1 | $32.1M | Sell |
1,551,521
-786,265
| -34% | -$16.3M | 9.3% | 3 |
|
2023
Q4 | $54M | Sell |
2,337,786
-1,153,135
| -33% | -$26.6M | 13.37% | 3 |
|
2023
Q3 | $27.9M | Sell |
3,490,921
-700,000
| -17% | -$5.59M | 24.59% | 3 |
|
2023
Q2 | $36.5M | Hold |
4,190,921
| – | – | 27.59% | 3 |
|
2023
Q1 | $12.3M | Hold |
4,190,921
| – | – | 7.13% | 5 |
|
2022
Q4 | $14.7M | Hold |
4,190,921
| – | – | 8.18% | 4 |
|
2022
Q3 | $33.2M | Hold |
4,190,921
| – | – | 13.7% | 4 |
|
2022
Q2 | $33M | Hold |
4,190,921
| – | – | 13.63% | 3 |
|
2022
Q1 | $50.9M | Hold |
4,190,921
| – | – | 12.31% | 3 |
|
2021
Q4 | $51.3M | Hold |
4,190,921
| – | – | 11.54% | 3 |
|
2021
Q3 | $43.7M | Hold |
4,190,921
| – | – | 9.69% | 3 |
|
2021
Q2 | $37.7M | Hold |
4,190,921
| – | – | 5.57% | 4 |
|
2021
Q1 | $42.6M | Hold |
4,190,921
| – | – | 6.66% | 4 |
|
2020
Q4 | $27.6M | Sell |
4,190,921
-1
| -0% | -$7 | 7.16% | 4 |
|
2020
Q3 | $21.8M | Hold |
4,190,922
| – | – | 11.58% | 5 |
|
2020
Q2 | $31.9M | Hold |
4,190,922
| – | – | 15.62% | 3 |
|
2020
Q1 | $42.7M | Hold |
4,190,922
| – | – | 27.52% | 2 |
|
2019
Q4 | $65M | Hold |
4,190,922
| – | – | 30.3% | 1 |
|
2019
Q3 | $75.9M | Hold |
4,190,922
| – | – | 47.25% | 1 |
|
2019
Q2 | $68.7M | Hold |
4,190,922
| – | – | 39.63% | 1 |
|
2019
Q1 | $75M | Buy |
4,190,922
+526
| +0% | +$9.42K | 37.35% | 1 |
|
2018
Q4 | $79.2M | Hold |
4,190,396
| – | – | 31.54% | 2 |
|
2018
Q3 | $150M | Buy |
4,190,396
+1,643,357
| +65% | +$58.7M | 31.11% | 1 |
|
2018
Q2 | $53M | Buy |
2,547,039
+1,686,407
| +196% | +$35.1M | 12.3% | 4 |
|
2018
Q1 | $10.5M | Buy |
+860,632
| New | +$10.5M | 2.3% | 7 |
|